Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Diagnostic Laboratory, |
RCV001260895 | SCV001437995 | pathogenic | Intellectual disability | 2020-09-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001879998 | SCV002234035 | pathogenic | Hereditary spastic paraplegia 50 | 2022-03-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 981454). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia (PMID: 33813722). This variant is present in population databases (rs777220438, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Gln4*) in the AP4M1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AP4M1 are known to be pathogenic (PMID: 24700674, 25496299, 25558065). |
Mayo Clinic Laboratories, |
RCV002246252 | SCV002520035 | likely pathogenic | not provided | 2021-04-19 | criteria provided, single submitter | clinical testing | PVS1, PM2 |
Zotz- |
RCV001879998 | SCV004099396 | pathogenic | Hereditary spastic paraplegia 50 | 2023-10-30 | no assertion criteria provided | clinical testing |